CN1810257A - Oral liquid of Huonaosu - Google Patents
Oral liquid of Huonaosu Download PDFInfo
- Publication number
- CN1810257A CN1810257A CNA200510071861XA CN200510071861A CN1810257A CN 1810257 A CN1810257 A CN 1810257A CN A200510071861X A CNA200510071861X A CN A200510071861XA CN 200510071861 A CN200510071861 A CN 200510071861A CN 1810257 A CN1810257 A CN 1810257A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- brain
- prescription
- arginine
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention discloses one kind of functional health food produced with animal brain tissue extracting liquid as main component and L-arginine, trimethyl glycine, tetrahydrofolic acid, citric aci, vitamin B2, vitamin B6, vitamin B12, menthol, etc as supplementary material. The functional health food is used in repairing damaged nerve cell of cerebral tissue as well as in improving memory and delaying senility.
Description
One, technical field
The present invention relates to a kind of health functional food prescription and preparation thereof that is used for the repair of the impaired neurocyte of brain tissue impairment and improves the memory slow down aging that a kind of animal brain extract and L-arginine, citric acid, stevioside etc. are made.
Two, background technology
Since nerve growth factor NGF finds, people recognize contains the abundant neural all kinds of factors in the animal brain, from the fresh animal cerebral tissue, extract all kinds of neural factors that have obvious biologic activity with modern biological extraction process, do not add any external reagent.Outer general property gangliosides material is with after neuron membrane combines, can increase every function of nerve growth factor, promote nerve growth, strengthen the nerve synapse projection, strengthen signal conduction between neurocyte, quicken and strengthen the effect of each function of nervous system, can promote to recover dormancy and impaired neurocyte function.
The L-arginine is to be used for substrate with the short nitric oxide that changes into of the action pathway that promotes the nitric oxide invertase, and then promotes vascular endothelial cell to recover elasticity and blood circulation promoting.NO is generated through nitricoxide synthase (NOS) catalysis by the L-arginine.Three kinds of approach of NO:
1. eNOS endothelium-at blood vessel endothelium is that the smooth muscle cell of blood vessel is loosened and blood vessel dilating.
2. nNOS nerve-at nerve synapse is to be used as the nerve conduction factor.
3. bringing out property of iNOS-can damage tumor cell and it is killed at macrophage stops its propagation.
4. NO has following physiological function in nervous system: (1) regulates neurohumoral release; (2) NO that is discharged by cerebrovascular endothelium and cerebrovascular adventitia autonomic nerve regulates the blood flow of brain; (3) activation by NOS in the neuron produces NO, influences the small artery in the brain, thereby regulates big cerebral blood flow.During the cerebrovascular infarction, multiple excitatory amino acid is discharged in the ECS, stimulates N-methyl D-asparagine acid acceptor, and extracellular calcium ion is entered in the neuron, activates NOS, and the NO of neuron generation and release is increased.During focal cerebral ischemia, also produce a large amount of NO in the brain.NO and O2 reaction form NO and cause cerebral lesion.Zoopery shows, if give SOD before the animal brain ischemia, can significantly reduce the Infarction volume of cerebral tissue.But excessive N OS inhibitor also can suppress the NOS activity of cerebrovascular endothelium, and the NO that endotheliocyte is produced reduces, and has hindered cerebral vasodilators, and has reduced the platelet adhesion inhibitory action, increases the weight of brain injury on the contrary.
Three, summary of the invention:
The object of the invention provides a kind of prescription and application thereof of the brain oral liquid of living.Its prescription is as follows:
Animal brain's extracting solution 0.1~2.%
L-arginine 0.1~10mg
Trimethyl glycine 0.1-30g
Vitamin B6 10-40mg
Vitamin B12 0.01-0.2mg
Tetrahydrofolic acid 0.5-2mg
Citric acid is transferred pH4.0-5.5
Menthol is an amount of
Lac regis apis is an amount of
Vitamin E 0-2mg
The present invention is achieved in that
With animal brain (pig, cattle, sheep, horse, monkey etc.) is raw material, after homogenate is smashed to pieces, heat to 95~100 ℃, and insulation 30mins~60mins, ℃ freezing 24hrs boils filtration after thawing again then-20.With the ultrafilter membrane molecular weight that dams is the brain activated protein and the peptide matters of the following molecular weight of 30,000 dalton, obtains brain active substance extracting solution, adds the prescription agent successively by the prescription amount, and fill becomes oral liquid formulations to get final product.
Claims (5)
1, a kind of repair that is used for the impaired neurocyte of brain tissue impairment of making such as a kind of animal brain's extract and L-arginine, trimethyl glycine, vitamin B6, vitamin B12, vitamin E, tetrahydrofolic acid, citric acid, menthol, Lac regis apis and health functional food prescription and the preparation thereof that improves the memory slow down aging.
2, according to 1 of claim the, its prescription is as follows:
Animal brain's extracting solution 0.1~2.%
L-arginine 0.1~10mg
Trimethyl glycine 0.1-30g
Vitamin B6 10-40mg
Vitamin B12 0.01-0.2mg
Tetrahydrofolic acid 0.5-2mg
Citric acid is transferred pH4.0-5.5
Menthol is an amount of
Lac regis apis is an amount of
Vitamin E 0-2mg
3, according to 1 of claim the, selecting the L-arginine for use is to be used for substrate with the short nitric oxide that changes into of the action pathway that promotes the nitric oxide invertase, and then promotes vascular endothelial cell to recover elasticity and blood circulation promoting.NO has following physiological function in nervous system: (1) regulates neurohumoral release; (2) NO that is discharged by cerebrovascular endothelium and cerebrovascular adventitia autonomic nerve regulates the blood flow of brain; (3) activation by NOS in the neuron produces NO, influences the small artery in the brain, thereby regulates big cerebral blood flow.
4, according to 1 of claim the, people's reported first such as Carson and Gerritsen the HHcy case, be a learning difficulty, the child that growth is quickened is contained the homocysteine of high concentration in its blood.Select trimethyl glycine, vitamin B6, vitamin B12, tetrahydrofolic acid prescription, can effectively reduce the homocysteine value of blood middle and high concentration, promote between brain neuroblastoma cell by the leading signal conduction of neurotransmitter.
5, according to 1 of claim the, be raw material with animal brain (pig, cattle, sheep, horse, monkey etc.), after homogenate is smashed to pieces, heat to 95~100 ℃, insulation 30mins~60mins, ℃ freezing 24hrs boils filtration after thawing again then-20.With the ultrafilter membrane molecular weight that dams is the brain activated protein and the peptide matters of the following molecular weight of 30,000 dalton, obtains brain active substance extracting solution, adds the prescription agent successively by the prescription amount, and fill becomes oral liquid formulations to get final product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA200510071861XA CN1810257A (en) | 2005-05-26 | 2005-05-26 | Oral liquid of Huonaosu |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA200510071861XA CN1810257A (en) | 2005-05-26 | 2005-05-26 | Oral liquid of Huonaosu |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1810257A true CN1810257A (en) | 2006-08-02 |
Family
ID=36843470
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA200510071861XA Pending CN1810257A (en) | 2005-05-26 | 2005-05-26 | Oral liquid of Huonaosu |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1810257A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010540636A (en) * | 2007-10-04 | 2010-12-24 | ネステク ソシエテ アノニム | Compositions and methods for enhancing cognitive function |
JP2011508773A (en) * | 2008-01-04 | 2011-03-17 | ネステク ソシエテ アノニム | Compositions containing unsaturated fatty acids and nitric oxide releasing compounds and their use to enhance cognitive function and related functions |
CN109497537A (en) * | 2018-11-16 | 2019-03-22 | 杭州天龙集团有限公司 | Flax nutraceutical and its manufacturing method for brain tonic |
RU2727586C1 (en) * | 2019-09-17 | 2020-07-22 | Общество С Ограниченной Ответственностью "Герофарм" | Polypeptide composition having property of normalizing cerebral functions |
-
2005
- 2005-05-26 CN CNA200510071861XA patent/CN1810257A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010540636A (en) * | 2007-10-04 | 2010-12-24 | ネステク ソシエテ アノニム | Compositions and methods for enhancing cognitive function |
JP2011508773A (en) * | 2008-01-04 | 2011-03-17 | ネステク ソシエテ アノニム | Compositions containing unsaturated fatty acids and nitric oxide releasing compounds and their use to enhance cognitive function and related functions |
CN109497537A (en) * | 2018-11-16 | 2019-03-22 | 杭州天龙集团有限公司 | Flax nutraceutical and its manufacturing method for brain tonic |
RU2727586C1 (en) * | 2019-09-17 | 2020-07-22 | Общество С Ограниченной Ответственностью "Герофарм" | Polypeptide composition having property of normalizing cerebral functions |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102772407B (en) | Pharmaceutical composition for promoting nerve damage restoration and application thereof | |
CN102524872B (en) | Ginseng peptide amino acid drink | |
KR101161634B1 (en) | Method for producing antler ferment solution with enhanced specific free amino acids content and antler ferment solution produced by the same method | |
DE202012011540U1 (en) | Food composition with amino acids and cocoa | |
CN106520875A (en) | Process for preparing selenium yeast protein peptide powder from selenium-rich yeast | |
CN108244444A (en) | Oyster Protein small-molecular peptides solid beverage and preparation method thereof | |
CN114561439A (en) | Hemoglobin polypeptide rich in heme iron and preparation method thereof | |
CN107475342A (en) | A kind of extracting method of snail active peptide | |
CN106420485A (en) | Oligopeptide skin smoothing rejuvenating powder | |
CN1810257A (en) | Oral liquid of Huonaosu | |
ES2282164T3 (en) | METHOD FOR PREPARING PEPTIDES RICH IN TRIPTOPHAN. | |
CN110915980A (en) | Sunflower disc peptide powder, and preparation method and application thereof | |
CN1597703A (en) | Low molecular potassium alginate and its application | |
CN114196718B (en) | A walnut protein hydrolyzate rich in arginine characteristic peptides and its preparation method and application | |
KR100482999B1 (en) | Health Beverage composition using the concentrate of Deep Ocean Water | |
CN108902324A (en) | A kind of person in middle and old age's high-calcium milk powder and preparation method thereof | |
CN114287638A (en) | Small molecule composite oligopeptide and preparation method and application thereof | |
CN106509761A (en) | Health-care product having cell repair factors and effects of building body, beautifying features and prolonging life | |
CN102948733B (en) | Production method and formula of special-eating life nutrition liquid | |
CN103494201B (en) | Osteoarticular disease care product of L-ascorbyl dipalmitate | |
CN100998861A (en) | Cerebroprotein hydrolysate sodium chloride injection | |
CN104888192A (en) | Sea cucumber glucosamine preparation for increasing bone mineral density, and production method thereof | |
CN1771992A (en) | Brain extract and its prepn and use | |
CN1821394A (en) | Method for extracting SOD enzyme from tilapia viscera | |
CN113832208B (en) | Preparation process, product and application of hydrolyzed protein composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Zhong Jianlin Document name: Correction notice |
|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |